Panbela Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 08 Nov 23 | SellUS$51,741 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 3,643.7 | US$14.20 |
Insider Trading Volume
Compra con información privilegiada: Datos insuficientes para determinar si personas con información privilegiada han comprado más acciones de las que han vendido en los últimos 3 meses.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 70 | 0,00144 % |
| Private Companies | 750 | 0,0155 % |
| Institutions | 7060 | 0,146 % |
| General Public | 4.837.981 | 99,8 % |
Dilución de acciones: Los accionistas se han visto sustancialmente diluidos en el último año, con un aumento del total de acciones en circulación de 19302%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1907 | US$1.0k | 0 % | no data | |||
| 1710 | US$934.8 | -4,58 % | no data | |||
| 1225 | US$669.6 | 0 % | no data | |||
| 794 | US$434.2 | 0 % | no data | |||
| 750 | US$410.1 | 176 % | no data | |||
| 622 | US$340.1 | 0 % | no data | |||
| 584 | US$319.2 | 0 % | no data | |||
| 212 | US$115.8 | 0 % | no data | |||
| 22 | US$11.9 | -18,5 % | no data | |||
| 22 | US$11.9 | -8,33 % | no data | |||
| 11 | US$6.1 | 10 % | no data | |||
| 7 | US$3.7 | -12,5 % | no data | |||
| 7 | US$3.7 | -12,5 % | no data | |||
| 3 | US$1.6 | 200 % | no data | |||
| 1 | US$0.5 | 0 % | no data | |||
| 1 | US$0.5 | 0 % | no data | |||
| 1 | US$0.5 | 0 % | no data | |||
| 1 | US$0.5 | 0 % | no data |